“…RSV also demonstrated inhibitory effect on NF- κ B activity and ameliorated the elevated levels of inflammatory proteins, TNF- α (tumour necrosis factor- α ), interleukin- (IL-) 6, and COX-2 (cyclooxygenase 2), thus contributing to reduction in neuroinflammation and protection against functional and behavioural deficits in diabetic neuropathy [106]. The anti-inflammatory property of RSV has been confirmed in diabetic animals by the downregulation of proinflammatory genes and proteins like TNF- α , IL-1 β , IL-6, IL-4, IL-17, COX-2 intercellular adhesion molecule 1 (ICAM), and vascular cell adhesion protein 1 (VCAM1) [14, 19, 22, 24, 107, 108] which are downstream targets of NF- κ B. In addition, RSV significantly decreased the activation and recruitment of macrophages thereby retarding the inflammation process in diabetic rats [22, 109].…”